NextPoint Therapeutics Logo logo
NextPoint Therapeutics Logo logo

NextPoint Therapeutics Logo

nextpointtx.com
nextpointtx.com • Likely startup • New
Likely startup • New
Actively hiring
Precision Medicine
Oncology Therapeutics
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
MPM BioImpact
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
MPM BioImpact fund
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs Yemaachi Biotechnology, Alixia
OrbiMed
backs Alterome
Canaan
backs Alterome
LAV
backs Tempest Therapeutics
M Ventures
backs TwoStep
Nextech Invest
backs Alterome
Similar startupsby what they do, their industry and backers
Alterome1 role
Alterome is a clinical-stage precision oncology company developing first-in-class, alteration-specific therapies for AKT E17K- and…
Umoja BiopharmaVenture round $210M · 5 yr ago • Founded 2019 • 4 roles
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
Tempest Therapeutics
Tempest Therapeutics is developing first-in-class small molecule product candidates with broad potential benefit to patients.
Yemaachi Biotechnology
Yemaachi is creating the world's most diverse cancer bio-database to develop the next generation of cancer drugs that are effective in…
TwoStep11-50 employees
TwoStep Therapeutics. Developing tumor-targeted therapies with broad applicability across solid tumors.
Betaglue® Therapeutics201-500 employees
BetaGlue Therapeutics — YntraDose®: a one-time, image-guided Yttrium-90 injection designed for durable local tumor control alongside…

Overview

Nextpoint Therapeutics is creating precision therapeutics that combine direct tumor cell killing and immunomodulation in each single molecule for long-term cancer control, featuring first-in-class assets.